Through our technical acumen in developing proprietary neural machine translation (NMT) technology, our linguistic expertise as the world’s largest language services provider and our 20+ years of experience with implementing AI-powered language technology for clients across all major industries, TransPerfect Life Sciences is uniquely positioned to bring the innovations happening in the wider industry to our partnership with Novo Nordisk.
TransPerfect initiated a proof of concept in November 2023 to assess the effectiveness of using a secure, generative AI-powered LLM solution in translating customer complaints. The focus was on addressing challenges in translating non-English customer texts, including errors in spelling, grammar, and syntax. Results:
In order to achieve the necessary quality for critical content streams and bring innovation to the way they are translated, TransPerfect has developed a framework for implementing MTPE-powered workflows based on the premise that MT should operate as a customizable program, rather than a plug-in.
This is an essential piece in our service offering since through Generative AI, P&G can reduce content generation costs by 50% and accelerate go-to-market timelines by 80%.